MedChem Imaging Inc. (MCI) is a leading contract research organization specializing in the chemistry of radioactive compounds for early-stage, in vitro research, and pre-clinical or clinical whole body imaging. With our state-of-the-art PET or SPECT technology, MCI's tracers offer valuable insights into molecular target abundance, occupancy, tumor uptake, and brain penetration over time.

At MedChem Imaging, we also excel in the design of non-radioactive and radioactive compounds for molecular imaging. Our expert team is dedicated to creating radiotracers that provide crucial information about target abundance, dose response, and the time course of tumor uptake or brain penetration. In addition, we offer a wide range of radiolabeled molecules, including 3 H, 11 C, 18 F, radioiodines, and radiometals, to meet diverse research needs.

Discover the exceptional capabilities of MedChem Imaging and unlock new possibilities in molecular imaging. Learn more about our innovative services and meet our talented team on our website. Contact us today to embark on a groundbreaking imaging journey.

MedChem Imaging, where science meets imaging excellence